Latest

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn

Find out more

You need to be a subscriber to read this article.
Click here to find out more.

When validated systems lose trust: why cyber risk is a Pharma 5.0 safety issue

Pharma 5.0 depends on connected, data-rich manufacturing environments, but cybersecurity weaknesses can undermine...
See more

Stevanato Group launches Deora pen injector platform targeting GLP-1 and incretin therapies

The fixed-dose, multi-use pull-push device accommodates volumes up to 0.75 mL, offering pharma partners a scalable, error-reducing delivery solution for diabetes and weight management programmes

GSK acquires Nuvalent for $10.6bn to accelerate NSCLC pipeline with FDA-reviewed ROS1 and ALK inhibitors

GSK has agreed to acquire clinical-stage oncology company Nuvalent for $10.6bn, securing two late-stage next-generation kinase inhibitors — zidesamtinib and neladalkib — currently under FDA review for potential 2026 approval in non-small cell lung cancer

UK healthcare M&A drops 26% in Q1 2026 amid geopolitical tension and financing pressures

Heligan Group's latest report records just 53 deals, down from 72 in Q1 2025, with pharma and life sciences remaining most active despite tighter financing conditions and prolonged deal timelines
You need to be a subscriber to read this article.
Click here to find out more.

ADC funding, spatial biology investment and haematology M&A signal biopharma pipeline momentum

From a $86.6m Series B for first-in-class ADCs to a $1.25bn haematology acquisition, this week's deals reflect sustained biopharma investment in next-generation therapeutic platforms

AMR Bio urges US policymakers to make infection prevention a core AMR strategy

Submitted ahead of PACCARB's 27th public meeting, AMR Bio's recommendations call for topical antimicrobials such as MRSA-active XF-73 to receive federal support alongside conventional antibiotic development
You need to be a subscriber to read this article.
Click here to find out more.

The path to commercial allogeneic iPSC therapies

The cell therapy sector is currently shifting from patient-specific autologous treatments toward off-the-shelf allogeneic cell therapies. Although this transition is helping to democratise access to treatments, it introduces several challenges in terms of controlling complex biology at a commercial scale

The IND advantage: why early derisking is a strategic imperative for complex biologics

As biologics grow more complex, early identification and the mitigation of manufacturability, stability and immunogenicity risks have become the critical factor separating programmes that reach IND on time from those that don't, says Yvette Stallwood, Head of Early Development Services at Lonza

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence

More stories

Analysis

Conjugation chemistry key to unlocking next-generation oligonucleotide therapies, says Bachem

As demand for oligonucleotide therapeutics accelerates, Bachem's Director of Oligonucleotide Production explains how conjugation chemistry is helping CDMOs overcome delivery challenges
Manufacturing

Why integrated outsourcing wins in modern drug development

Aligning drug substance and drug product development within a single outsourcing model accelerates timelines, sharpens CMC decisions and reduces risk by enabling parallel workstreams and shared governance
Sustainability

Vetter named Best Managed Company for seventh year in a row

The CDMO was the only company to be awarded Platinum status, having been recognised for its strategic focus, economic success and sustainability targets
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Pharma supply chains face record drug shortages as geopolitical, cyber and quality risks converge

A new Moody's report identifies four compounding risk factors driving pharmaceutical supply chain instability and warns that siloed risk management is leaving the sector dangerously exposed
Drug Delivery

AI-designed drug product enters clinical development

Phase I study of an AI-designed oral formulation sets a new standard in drug development
Research & Development

Stipple Bio enters into multi-target license agreement with Lonza to advance precision oncology ADC therapies

Stipple Bio’s Pointillist Platform identifies tumour-specific cell surface epitopes that, when combined with Lonza’s clinically validated ADC platform, may enable first-in-class and best-in-class ADC oncology medicines such as STP-100
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

NICE approval is not enough: why the UK’s next medicines challenge is operational delivery

A medicine is not truly accessible until it can be manufactured, procured, stocked, prescribed, dispensed and delivered reliably. That distinction is becoming increasingly important, says Varun Cruz, founder of NEUVIOR
Finance

Strengthening US pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA

SCHOTT Pharma has inaugurated new production lines for both standard and sterile ready-to-use (RTU) glass vials designed to store a wide range of drugs — from biologics and other complex injectable therapies to vaccines and emergency room medications
Manufacturing

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

Purification: a critical success factor in peptide programmes

This article examines why advanced chromatography, process intensification and sustainability initiatives can help manufacturers to improve process efficiency and long-term supply security
Ingredients

NorthStar and QSA Global sign multi-year partnership to secure actinium-225 supply chain

NorthStar Medical Radioisotopes and QSA Global have announced a new strategic services agreement to support commercial-scale production of actinium-225 through a closed-loop radium-226 target supply and recycling programme for targeted alpha therapies

Sponsor content

Lonza appoints Hans Trees as Global Head of Communications

Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans...

Safe and accurate flow measurement for pharmaceutical production

Oval Gear (OG) meters from Titan Enterprises, fitted with a Namur sensor, provide consistent, accurate measurement across a wide range of liquids, from low-viscosity...

Cutting-edge wiped film evaporator installation – non-tobacco nicotine products

Successful system installation for a UK research and development facility developing and commercialising non-tobacco nicotine products using industry-leading evaporation...

What to expect from a regulatory inspection: An NSF expert guide

Prepare with confidence. NSF’s expert guide shows what inspectors look for, common pitfalls and how to ensure lasting inspection readiness

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity...

Redefining safety, efficiency, and sustainability: SCHOTT Pharma launches next generation polymer syringe system

A new cap design for prefillable polymer syringes provides tamper evidence at the individual syringe level, significantly reducing the risk of drug waste and ensuring...

Bruker announces major strides in 4D proteomics performance, further advances In intact and top-down functional proteoform analysis, and innovations in hybrid qual/quant 4D metabolomics

All to enable deeper insights into disease biology. Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in...

It all starts in a lab: Telstar at Expoquimia 2026

Telstar showcases laboratory and R&D solutions designed to support pharmaceutical and biotech companies from early research through seamless scale-up to industrial production

Precision-engineered glass reaction and distillation systems up to 150 litres

Labtex supplies industry-leading glass reactors from DIEHM with bespoke automation, temperature control, stirring and vacuum capabilities

Guardware Cleanroom Hardware helping Life Sciences, Healthcare and High-Tech Engineering applications show their true colours

Guardtech’s furniture & equipment specialists are providing elite hardware solutions for some of the leading lights in ground-breaking science and engineering sectors

Reducing fluid control and automation complexity in pharma process development

Aligning mechanical, electrical, instrumentation, and automation engineering through compatible technologies can reduce development risks and accelerate pharmaceutical...

Almac group delivers record year of growth

Revenue rises to £1.1 billion as profit increases 16% and workforce expands to more than 7,900 amid continued global investment programme

Featured companies

As a dedicated CDMO serving the healthcare industry, we bring life-enhancing and life-saving treatments to market for our customers and their patients. We are a pioneer and... With over 40-years’ experience in flow meter innovation, Titan Enterprises Ltd are a leading UK-based manufacturer and supplier of high-performance liquid flow measuring... GEA is a leading provider of process technology and packaging solutions for the pharmaceutical, biopharmaceutical, biotechnology and nutraceutical industries. Our portfolio... Advanced Drug Containment and Delivery Solutions from SCHOTT Pharma
See more

Resource Centre

Latest Media See all

From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND

From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND

Manufacturing Chemist Stand Side with GEA and Hovione

Manufacturing Chemist Stand Side with GEA and Hovione

Manufacturing Chemist Stand Side with Piramal Pharma Solutions

Manufacturing Chemist Stand Side with Piramal Pharma Solutions

Manufacturing Chemist Stand Side with Almac Group

Manufacturing Chemist Stand Side with Almac Group

Latest Reports See all

Panthera joins the Association of Multisite Research Corporations (AMRC)

Membership strengthens Panthera’s ability to collaborate across the industry, contribute to collective advocacy and help shape the future of clinical research

Terminal sterilisation versus aseptic filling: ensuring drug product safety

The sterility of drug products is critical to patient safety. Choosing between terminal sterilisation or aseptic processing to achieve this should reflect the final product’s...

US mRNA policy shift: are vaccine headwinds accelerating oncology focus?

With Washington’s stance on mRNA vaccines cooling, Manufacturing Chemist examines whether policy and funding signals could influence the pharmaceutical industry’s most...

Reimagining biosimilars: faster access, stronger supply, sustainable healthcare

Outdated development models, uneven adoption and policy barriers are holding Europe back. Dr Kevin Robinson (KSR) spoke to Matt Erick (ME), Head of Advanced Markets at Biocon...

Company News

Rezon Bio appoints Dr. Ralf Otto as Chief Operating Officer to support next phase of growth and operational expansion Rezon Bio, a science-driven European biologics contract development and manufacturing organization (CDMO), today announced the appointment of Dr. Ralf Otto, as Chief Operating...
Ardena appoints Ariane de Ganck as Chief Scientific Officer Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and complex therapies, today announced the appointment of Ariane de Ganck, PhD, as...
MasterControl strengthens executive leadership team with two key appointments ynn Clayton joins as CFO while Ian Ball is promoted to chief sales officer to support the company’s next phase of growth
IMCD appoints Behnosh Yaghobi as Managing Director Middle East Industry leader to drive the next phase of regional growth
Hovione announces leadership transition and interim Co-CEO structure Co-CEOs for the transition period, António Almeida and Dr. Marco Gil, bring combined 40 years of experience with Hovione to their new role
CellProthera appoints new board members for late-stage clinical development CellProthera, a clinical-stage biotechnology company developing regenerative cell therapies for ischemic diseases, today announced the appointment of Jérôme Hirtzlin and Anne...
AES Cleanroom Technology appoints John Groth as Chief Revenue Officer AES Cleanroom Technology, a leading provider of modular cleanroom design, manufacturing, and construction solutions for the life sciences and biopharmaceutical industries, has...
Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth ProBioGen announced the appointment of Dr. Simon Johannes Bulling, PhD, as Chief Operating Officer (COO), effective April 15, 2026
See more

Upcoming events See all

BIO International Convention

22–25 June 2026 | Convention | Boston, US

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy

About Manufacturing Chemist

Through digital, live and print products, Manufacturing Chemist informs and inspires business leaders and decision-makers around the world. With a digital-first strategy, the Group’s Editors write breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry from ingredients and packaging to regulation, retail and marketing.

Pharma 5.0 represents a paradigm shift in pharmaceutical manufacturing, paving the way for a future where medications are developed faster, customised to individual patient needs and delivered with uncompromising quality. It is not just about innovation; it is about transforming the way we think about healthcare and ultimately improving the lives of patients around the world.